Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Baxdela meets the primary endpoints in confirmatory phase III study

May 17, 2016

Tetraphase receives FDA guidance on eravacycline program

May 13, 2016

Vaccitech launched from Oxford Sciences

May 13, 2016

CIADM begins advanced development of anthrax vaccine

May 12, 2016

Novel pGX2303 vaccine provides full protection against RSV in animal model

May 12, 2016

Phase I/II results for novel maternal trivalent GBS vaccine

May 12, 2016

US Phytotherapy conducting preclinical studies of PROACT-Z for Zika infection

May 11, 2016

Janssen plans phase IIb study of AL-335, odalasvir and simeprevir combinations for chronic HCV

May 11, 2016

VBI Vaccines and SciVac Therapeutics complete merger

May 10, 2016

CSIR discloses antimalaria compounds

May 10, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...